Leptin overexpression is closely correlated with gastric cancer (GC) invasion, but its exact effect and the underlying mechanism in tumorigenesis remain poorly understood. Membrane type 1-matrix metalloproteinase (MT1-MMP), a surface-anchored 'master switch' proteinase, is overexpressed and plays crucial roles in tumor invasion. Here, we characterized the influence of leptin on the generation and surface localization of MT1-MMP in GC and elucidated its molecular mechanisms. Our results revealed that leptin promoted GC cell invasion in vitro by upregulating MT1-MMP expression. Furthermore, cell surface biotinylation assay and flow cytometry demonstrated that the surface expression of MT1-MMP was also enhanced by leptin, and knockdown of kinesin family member 1B (KIF1B, a microtubule plus end-directed monomeric motor protein) by small interference RNA inhibited this process. Notably, coimmunoprecipitation analysis indicated that leptin enhanced the interaction of MT1-MMP with KIF1B in a time-dependent manner, which consequently contributed to GC cell invasion. Moreover, leptin increased MT1-MMP or KIF1B expression by the protein kinase B (AKT) pathway and extracellular signal-regulated kinase 1/2 partially participated in this process. However, only AKT was implicated in the leptin-mediated membrane localization of MT1-MMP. Immunohistochemistry analysis revealed that leptin, MT1-MMP and KIF1B are overexpressed in GC tissues, and they positively correlated with clinical stage and lymph node metastasis. These observations indicate that this regulatory network exists in vivo. Taken together, our findings suggest that leptin is an effective intracellular stimulator of MT1-MMP and that leptin-enhanced cell surface localization of MT1-MMP is dependent on KIF1B, which consequently plays a critical role in GC invasion.
Introduction
Gastric cancer (GC) ranks as the second leading cause of cancer-related death worldwide (1) . It is highly aggressive and rapidly metastasizes, which contributes to its high mortality rate (2) . Multiple factors are involved in this process, including obesity, an important risk factor in GC (3, 4) . Leptin, the 16 kDa protein product of the obese gene, is implicated in tumorigenesis (5, 6) . Leptin exerts its function through leptin receptor (7, 8) and the use of leptin receptor antagonists has been investigated as a potential therapeutic approach (9) . Converging studies reveal that leptin is elevated in GC patients and induces GC cell proliferation (10, 11) . Moreover, leptin expression is also significantly correlated with GC invasion (6, 12) . These studies suggest that leptin may be a novel growth factor that is involved in the development of GC. Therefore, further exploration of the role of leptin in GC invasion is of great importance. However, the underlying mechanism of how leptin mediates tumor cell invasion in GC remains unclear.
Membrane type 1-matrix metalloproteinase (MT1-MMP, MMP-14), a 'master switch' proteinase with a C-terminal sequence that acts as membrane-anchoring domain, is one of the critical factors during tumor invasion (13) . Once on the cell surface, MT1-MMP cleaves a variety of substrates including collagens, other MMPs such as pro-MMP-2 and pro-MMP-13 and cell surface proteins such as CD44. All these activated target molecules are implicated in remodeling the extracellular matrix (13) (14) (15) . Previous studies show that MT1-MMP is elevated in GC patients, and MT1-MMP overexpression is closely associated with GC invasion (16, 17) . MT1-MMP expression is tightly regulated via mechanisms at the transcriptional level (18) , intracellular trafficking to the cell surface (19, 20) and inhibition by endogenous tissue inhibitors (TIMP-2 and RECK) (21, 22) . Recently, the production and expression of MT1-MMP at the cell surface has been delineated during GC invasion (23) .
The cell surface localization of MT1-MMP, which is essential to exerting its proinvasive activity, is likely to be related with kinesin superfamily proteins (KIFs) (20) . KIFs are a cluster of microtubuledependent motors, which play functional roles during cell division (24) and intracellular transport of organelles, protein complexes and vesicles (25) (26) (27) . We revealed previously that overexpression of KIF2A-enhanced proliferation and invasion of oral tongue cells in squamous cell carcinoma (28) . Kinesin family member 1B (KIF1B), a monomeric mitochondrial transporter, is also involved in GC (29, 30) . Altogether, these findings suggest that KIFs play an important role in tumorigenesis. Recent studies show that several members of KIFs (KIF3B, KIF5B) promoted macrophage migration by regulating trafficking of MMPs including MMP-9 (20, 31) . This suggests that KIFs might be involved in tumor development by interacting with MMPs. However, the link between MT1-MMP and KIFs in GC has not been investigated.
Recent findings of upregulation of MMP-2 (32) and MMP-13 (5) by leptin may shed light on how leptin modulates tumor invasion. These are further supported by the finding that leptin regulates myocardial matrix remodeling by regulating MMP-2 and MT1-MMP in cardiac fibroblasts (33) . However, the exact effect and mechanism of leptin on the expression and surface localization of MT1-MMP during GC invasion remain unknown. In this study, our results confer a novel regulatory mechanism that increased MT1-MMP by leptin involves KIF1B-dependent surface localization with protein kinase B (AKT) signaling implicated in this process. These findings may provide a potential therapeutic target to attenuate early stage development of GC and tumor cell invasion.
Materials and methods

Patients and specimens
Archived paraffin-embedded GC tissues and matched adjacent normal gastric tissues were collected from 86 patients who underwent surgery for primary gastric carcinoma in Department of General Surgery, Qilu Hospital, Shandong University (Shandong, China). The clinical parameters and pathologic classifications are presented and summarized in Table I . All patients had not received medical therapy before surgery. The diagnosis of each case was confirmed by two pathologists. The research was approved by the Ethics Committee of Qilu Hospital and we obtained written informed consent from all patients.
Leptin regulates MT1-MMP in gastric cancer
Reagents and antibodies Cucurbitacin I, U0126 and LY294002 were obtained from Cell Signaling Technology (Boston, MA). Leptin neutralizing monoclonal antibody (mAb) was from Santa Cruz Biotechnology (Santa Cruz, CA). Recombinant human leptin (rhleptin) and leptin commercial ELISA kit were obtained from R&D Systems (Minneapolis, MN). Other antibodies used in the current study are summarized in Supplementary Table S1 , available at Carcinogenesis Online.
GC cell lines and cell culture
The human GC AGS, MKN-28 and MKN-45 cells from the Culture Collection of the Chinese Academy of Sciences (Shanghai, China) and the Riken Cell Bank (Tsukuba, Japan) were grown in Dulbecco's modified Eagle's medium/ F12 medium containing 10% fetal calf serum (Hyclone-Pierce, Rockford, IL) . Cells were seeded upon 80% confluence. In the following experiments, cells were serum deprived for 12 h prior to the administration of exogenous stimulation and then incubated with serum-free Dulbecco's modified Eagle's medium/ F12 medium excluding special indication.
Transient transfection in AGS cells
The vector pcDNA™3.1/myc-His A was kindly provided by Dr Yinghong Xiao (Raul Andino Lab, Department of Microbiology and Immunology, University of California, San Francisco). The human full-length MT1-MMP cDNA (Genbank: NM_004995) was amplified and subcloned between the EcoRI and BamHI sites of the vector to construct eukaryotic expression vector pcDNA3.1-MT1-MMP in Central Research Laboratory (Bethune Second Hospital of Jilin University, Changchun, China). Cells per well (2 × 10 5 cells per well) were seeded onto 6-well plates and then transfected with pcDNA3.1-MT1-MMP or an empty vector (MOCK) as control, using Lipofectamine2000 (Invitrogen, Carlsbad, CA) following the manufacturer's protocol. After 24 h, the transfection efficacy was evaluated.
Immunohistochemical analysis
Paraffin-embedded tissues were deparaffinized and rehydrated. After antigen retrieval, all tissues were exposed to primary antibody (leptin, 1:400; MT1-MMP, 1:100; KIF1B, 1:100) overnight at 4°C, and then incubated with biotin-conjugated secondary antibodies (1:2000) for 30 min at 37°C, followed by avidin-biotinylated peroxidase complex. Staining was observed with 3,3N-diaminobenzidine tertrahydrochloride and evaluated by two pathologists. An immunohistochemical score was generated as described previously (34) .
Cell invasion assay
For transwell Matrigel invasion assay, 5 × 10 4 cells in 200 μl of serumfree medium were plated onto the upper chamber of 24-well transwell inserts (8 μm pores, BD Biosciences, Bedford, MA) coated with or without Matrigel, as described previously (35) . Cells were incubated for 1 h for adherence, and leptin or anti-leptin mAb (10 μg/ml, added 2 h prior to leptin treatment) was then added in the upper chamber for another 24 h at 37°C in 5% CO 2 . The lower chamber was filled with 600 μl medium containing 10% fetal calf serum. After 24 h, the non-invaded cells were gently scraped off by cotton swab. The migrated cells were fixed by 10% formalin and stained with eosin and counted. Three fields of each well were photographed and cell numbers were determined by Kodak MI software. Meanwhile, the migration cells in well without Matrigel were counted. The invasion index was calculated as the ratio of the number of cells invading through the Matrigelcoated chambers to the number of cells migrating through chambers without Matrigel coating.
For transwell collagen invasion assay, the type I collagen stock was neutralized with 100 mM Na 2 CO 3 (pH 9.6) to a final concentration of 0.4 mg/ml. Cells (5 × 10 4 ) in 200 μl of serum-free medium were plated onto the upper *P < 0.05; **P < 0.01.
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chamber of 24-well transwell inserts coated with or without collagen. The following procedures were the same as described in transwell Matrigel invasion assay.
Gelatin zymography
Cell culture supernatants were collected and centrifuged at 300g for 5 min. Cell-free supernatants (10 μg) were electrophoresed on 8% sodium dodecyl sulfate-polyacrylamide gel containing gelatin (1 mg/ml) as described previously with minor modification (23, 33) . Following electrophoresis, gels were washed twice for 45 min in 2.5% Triton X-100 to remove sodium dodecyl sulfate and subsequently incubated in buffer (50 mM Tris-HCl, 150 mM NaCl, 5 mM CaCl 2 , 1 μM ZnCl 2 and 0.02% NaN 3 , pH 7.5) at 37°C overnight. Thereafter, gels were stained with 0.5% (w/v) Coomassie brilliant blue G-250 for 4 h to identify proteolytic activity of MMP-2. Gels were scanned and images were converted to black and white for quantification.
Reverse transcription-polymerase chain reaction
Total RNA was extracted using TRIzol reagent (Invitrogen) and reverse transcribed to cDNA, as described previously (36) . PCR was performed using the primers (Supplementary Table S2 , available at Carcinogenesis Online). The products were separated on 1.8% agarose gel and visualized by ethidium bromide.
Western blotting and coimmunoprecipitation
Cells or tissues were lysed on ice, as described previously (37) . Equal amounts of proteins from each sample were separated on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels and transferred onto nitrocellulose membranes. The membranes were blocked for 1 h at room temperature with TBST (50 mM Tris-HCl, 150 mM NaCl, 0.05% Tween-20, pH 7.0) containing 5% non-fat dry milk and then incubated with the primary antibody [MT1-MMP (1:500), KIF1B (1:200), OB-RL (1:500), signal transducers and activators of transcription-3 (STAT3; 1:1000), extracellular signal-regulated kinase 1/2 (ERK1/2; 1:700), AKT (1:500), P-STAT3 (1:500), P-ERK1/2 (1:500), P-AKT (1:500) and β-actin (1:2000)] overnight at 4°C. The membranes were exposed to the horseradish peroxidase-labeled secondary antibodies (1:2000) for 1 h at room temperature and then were detected by enhanced chemiluminescence detection system (Amersham, Pittsburg, PA). For coimmunoprecipitation, cell lysates were precleared with Protein A/G Plus-Agarose (Santa Cruz Biotechnology) overnight at 4°C and incubated with anti-MT1-MMP antibody or anti-KIF1B antibody (3 μg antibody per 1 mg protein sample) for 4 h at 4°C, as described previously (31, 38) . The immunocomplex was incubated with Protein A/G Plus-Agarose overnight at 4°C, washed three times with lysis buffer and boiled in loading buffer. Proteins were resolved on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotted with anti-KIF1B or anti-MT1-MMP antibody. The following procedures were the same as described for western blotting.
RNA interference
Small interference RNA (siRNA) constructs targeting MT1-MMP (numbered 1-3) and KIF1B (numbered 1-3) and stable negative control were designed and purchased from GenePharma Co., Ltd (Shanghai, China). For transient silencing, 2 × 10 5 /ml cells were seeded onto 6-well plates and transfected with MT1-MMP-siRNA (80 nmol/l) or KIF1B-siRNA (80 nmol/l) using Lipofectamine RNAiMAX reagent (Invitrogen), following manufacturer's protocol. The sequences are summarized in Supplementary Table S3, available at Carcinogenesis Online.
Cell surface biotinylation
Cells were incubated with 1 mg/ml Sulfo-NHS-Biotin (Pierce, Rockford, IL) for 30 min on ice and 200 mM Tris-HCl (pH 8.0) neutralized reaction for 20 min, as described previously (33) with minor modification. Equal protein from each sample was incubated with streptavidin-agarose complex (Pierce) overnight at 4°C and heated for 5 min at 65°C in loading buffer containing β-mercaptoethanol. Proteins were separated on 10% sodium dodecyl sulfatepolyacrylamide gel electrophoresis and immunoblotted with anti-MT1-MMP antibody.
Flow cytometric analysis
Cells were collected and incubated with anti-MT1-MMP mAb for 1 h at room temperature and then incubated with Phycoerythrin-goat anti-mouse secondary mAb (1:1000, Invitrogen) for 30 min at room temperature. Then cells were measured by FACSCalibur (BD Biosciences), and the data were analyzed by the software WinMDI 2.8.
Enzyme-linked immunosorbent assay
Cell culture supernatants were collected and centrifuged at 300g for 5 min. Leptin levels in the cell-free supernatants were detected using a commercial ELISA kit (R&D Systems) according to the manufacturer's instruction.
Statistical analysis
Data were mostly presented as the mean ± SD. SPSS software package (version 13.0; SPSS, Chicago, IL) was used for all statistical analysis. The distribution of the samples was determined by Kolmogorov-Smirnov test. Correlations of leptin, MT1-MMP and KIF1B expression with clinicopathologic factors were analyzed by Kruskal-Wallis test or Mann-Whitney U-test, as appropriate. Chi-square test was applied to analyze the correlation of leptin, MT1-MMP and KIF1B. Other data from experiments were analyzed by paired Student's t-test or one-way analysis of variance wherever appropriate. Tukey post hoc comparison was performed when statistical significance (P < 0.05) was found between observations. Each variable was tested twice and the experiment was repeated three times.
Results
Leptin induced the invasion of human GC cells
Previous studies indicated that leptin induced invasion in several tumors, such as breast cancer (32), glioma (5) and GC (3, 4, 39) . To investigate the effects of leptin on GC, we examined Matrigel invasion assay by administrating different doses of leptin (0, 50, 100, 250 and 500 ng/ml) in AGS cells. Leptin significantly increased cell invasion in a dose-dependent fashion and blocking by leptin neutralizing mAb (10 μg/ml) abrogated this process ( Figure 1A and B). Furthermore, leptin (100 ng/ml, a dose that was close to physiological level) (40) could differentially induced GC cells invasion [leptin sensitivity: AGS (3.81 ± 0.39-fold, P = 0.006) > MKN-45 (2.76 ± 0.23-fold, P = 0.005) > MKN-28 (1.83 ± 0.18-fold, P = 0.016)] ( Figure 1C ). Recent studies show that type I collagen, which forms fibrillar networks, may be degraded by MT1-MMP, thereby contributing to cellular invasion (13, 41) . To investigate the effects of leptin on the collagen invasion, we performed transwell collagen invasion assay to parallel transwell Matrigel invasion assay. Our results demonstrated that GC cells penetrated the collagen I barrier, and the ability of GC cells to clear collagen as well as the invasion was significantly enhanced by leptin (Supplementary Figure S1A and B, available at Carcinogenesis Online).
To test whether GC cell-derived leptin could promote invasion, we first confirmed leptin expression in the GC cell lines. Leptin mRNA and protein were detected at varied levels (AGS > MKN-45 > MKN-28) (Supplementary Figure S2A and B, available at Carcinogenesis Online). In addition, we detected secrete leptin in cultured supernatants of AGS (43.81 ± 4.11 pg/ml), MKN-28 (25.95 ± 1.44 pg/ml) and MKN-45 (34.28 ± 2.67 pg/ml) (Supplementary Figure S2C , available at Carcinogenesis Online). Furthermore, Figure 1C revealed that leptin neutralizing mAb resulted in decreased invasion compared with control. However, no significant differences were observed (P > 0.05). Taken together, these results suggest that leptin may enhance tumor cell invasion of GC.
Leptin enhanced the expression of MT1-MMP of human GC cells
Upregulation of MT1-MMP plays important roles in GC development (16, 17, 23) . To investigate whether MT1-MMP is regulated by leptin, we examined MT1-MMP expression by introducing leptin. As shown in Figure 1D and E, leptin (100 ng/ml) significantly increased MT1-MMP expression in AGS cells at both the mRNA (3.01 ± 0.48-fold, P = 0.010) and protein (3.77 ± 0.99-fold, P = 0.009) levels. Moreover, cell surface MT1-MMP was enhanced by leptin ( Figure 1F It has been reported that capacity for pro-MMP-2 activation is evaluated by assessing MT1-MMP activity (13) . To determine whether MMP-2 activation in GC cells is regulated by leptin, we performed zymography assay. The results revealed that leptin enhanced the proteolytic activity of the ~72 and ~62 kDa band corresponding to pro-MMP-2 and active MMP-2, respectively (AGS: 1.73 ± 0.1-fold, 4 cells in the volume of 200 μl) were plated onto the upper chamber. Cells were incubated for 1 h for adherence and then treated with either Dulbecco's modified Eagle's medium (basal) or varying concentrations of leptin (50-500 ng/ml) in the upper chamber for 24 h in the presence or absence of anti-leptin mAb (10 μg/ml, added 2 h before leptin treatment). The invasion was measured by transwell assay. Scale bar, 50 μm. (C) The cells (AGS, MKN-28 and MKN-45) were treated without (basal) or with leptin (100 ng/ml) as described above. The invasion ability was shown as invasion index and expressed as relative to basal. In a separate experiment, AGS cells (2 × 10 5 cells per well) were seeded onto 6-well plates and were serum deprived for 12 h when confluence attained 80%. Then cells were treated without (basal) or with leptin (100 ng/ml) in the presence or absence of anti-leptin mAb (10 μg/ml, added 2 h before leptin treatment) in serum-free medium for 24 h. The expression of MT1-MMP was measured by RT-PCR (D) and western blotting (E). The surface expression of MT1-MMP was measured by biotinylation immunoblot (F) and flow cytometry (G). One representative result out of three independent experiments is shown. Graphs show quantitation of MT1-MMP using glyceraldehyde 3-phosphate dehydrogenase or β-actin as the internal standard. Each bar represents the mean ± SD (n = 3, *P < 0.05, **P < 0.01). P = 0.006; MKN-45: 1.55 ± 0.09-fold, P = 0.008; MKN-28: 1.33 ± 0.07-fold, P = 0.013. Supplementary Figure S3A and B, available at Carcinogenesis Online).
Increased cell surface localization of MT1-MMP mediated by leptin was dependent on KIF1B
MT1-MMP at the cell surface is required for its biological function (13) . It has been reported that the KIFs (KIF3A, KIF3B and KIF5B) may be involved in the cell surface process of MMP-9 or MT1-MMP in macrophages (20, 31) . To investigate whether KIFs contribute to leptin-mediated upregulation of cell surface MT1-MMP in GC, we examined the effect of leptin on KIFs (KIF3A, KIF3B and KIF5B) expression by reverse transcription-polymerase chain reaction (RT-PCR) in AGS cells. No difference was observed (Supplementary Figure S4 , available at Carcinogenesis Online). A recent study showed that KIF1B is involved in GC development (30) . We, therefore, investigated the effect of leptin on KIF1B expression. The findings showed that leptin significantly increased KIF1B at both the mRNA (Figure 2A, 3 .34 ± 0.12-fold, P = 0.007) and protein levels ( Figure 2B, 3 .52 ± 0.18-fold, 5 cells per well) were seeded onto 6-well plates and were serum deprived for 12 h when confluence attained 80%. Then cells were treated without (basal) or with leptin (100 ng/ml) in the presence or absence of anti-leptin mAb (10 μg/ml, added 2 h before leptin treatment) in serum-free medium for 24 h. KIF1B was detected by RT-PCR (A) and western blotting (B). In addition, AGS cells were treated without (basal) or with leptin in the presence or absence of KIF1B-siRNA (80 nmol/l, added 24 h before leptin treatment) for 24 h. The expression of MT1-MMP was measured by RT-PCR (C) and western blotting (D). The surface expression of MT1-MMP was detected by biotinylation-immunoblot analysis (E) and flow cytometry (F). One representative result out of three independent experiments is shown. Graphs show quantitation using glyceraldehyde 3-phosphate dehydrogenase or β-actin as the internal standard. Each bar represents the mean ± SD (n = 3, **P < 0.01). (G) In a separate experiment, AGS cells (2 × 10 5 cells per well) were seeded onto 6-well plates and were serum deprived for 12 h when confluence attained 80%. Cells were then incubated without (basal) or with leptin (100 ng/ml) for 24 h in the presence or absence of KIF1B-siRNA or MT1-MMP-siRNA, alone or combination. The invasion index was calculated and expressed relative to basal. Data shown represented the mean ± SD (n = 3, *P < 0.05, **P < 0.01 compared with the group of leptin (100 ng/ml), # P < 0.05 compared with the group of leptin + KIF1B-siRNA alone). P = 0.002), and leptin neutralizing mAb (10 μg/ml) abrogated these processes. We next investigated the possible link between KIF1B and leptin-induced MT1-MMP expression. By blocking KIF1B expression using siRNA, we found that MT1-MMP mRNA and protein expression were not significantly affected after 24 h of leptin stimulation ( Figure 2C and D) . However, the cell surface localization of MT1-MMP induced by leptin was significantly reduced (48.1 ± 4.0%) ( Figure 2E , P = 0.003), and the similar trend applied to flow cytometric analysis (49.24 ± 5.35%, P = 0.006, Figure 2F ). These results suggest that KIF1B might play a role in the cell surface localization of MT1-MMP mediated by leptin in GC cells.
Increased MT1-MMP and KIF1B expression potentiated invasiveness induced by leptin
To determine whether MT1-MMP and KIF1B regulate leptinmediated invasion of AGS cells, we knockdown these two factors by siRNA. The knockdown efficiency was greatest using siRNA constructs 1 and 3 to silence MT1-MMP and KIF1B, respectively (Supplementary Figure S5 , available at Carcinogenesis Online). Figure 2G shows that leptin-mediated invasion of AGS cells was significantly reduced by MT1-MMP-siRNA (62.8 ± 4.5%, P = 0.005) and KIF1B-siRNA (45.2 ± 6.5%, P = 0.016) either separately or in combination (71.1 ± 3.7%, P < 0.001). Notably, the invasion was further reduced after combinational knockdown of both factors compared with KIF1B alone (P < 0.01), but not MT1-MMP alone (P = 0.056). These results further reveal that the upregulation of KIF1B and MT1-MMP expression plays an essential role in leptinenhanced invasion of GC cells.
Leptin enhanced the interaction between KIF1B and MT1-MMP, which consequently contributed to the membrane localization of MT1-MMP
To further investigate the role of KIF1B for cell surface localization of leptin-induced MT1-MMP, we examined the interaction between KIF1B and MT1-MMP in AGS cells. KIF1B and MT1-MMP interacted with each other as determined by coimmunoprecipitation ( Figure 3A) . To investigate the effect of leptin on the interaction between KIF1B and MT1-MMP, we transduced AGS cells to overexpress MT1-MMP1 (pcDNA3.1-MT1-MMP), since leptin simultaneously enhances the expression of KIF1B and MT1-MMP. The transfection efficacy was analyzed by RT-PCR and western blotting (Supplementary Figure S6 , available at Carcinogenesis Online). We performed coimmunoprecipitation to pull down KIF1B and examined the association with MT1-MMP in the presence of leptin at different time points. As shown in Figure 3B and C, MT1-MMP in the whole cell lysate was at a high level and the expression of MT1-MMP was not affected by leptin treatment. Furthermore, KIF1B and its interaction with MT1-MMP were increased after leptin induction for 12, 24 or 48 h, but not for 6 h. Particularly, higher expression of MT1-MMP than KIF1B was observed 48 h after leptin treatment. Taken together, our results suggest that KIF1B increases cell surface localization of leptin-induced MT1-MMP.
Signaling pathways regulating the expression and membrane localization of MT1-MMP mediated by leptin
Leptin exerts its action by binding to the long isoform of the leptin receptor (termed OB-RL). OB-RL could be detected in unstimulated cells and was enhanced with leptin stimulation (P = 0.030), suggesting that leptin might induce a compensatory upregulation of OB-RL ( Figure 4A ). Ligand binding to OB-RL can activate several intracellular signaling pathways including signal transducers and activators of transcription-3 (STAT3), ERK1/2 and AKT (7). Our data revealed that leptin induced the phosphorylation of STAT3, ERK1/2 and AKT at 15, 30 and 30 min, respectively ( Figure 4B ). To investigate which pathway(s) was involved in leptin-mediated MT1-MMP and KIF1B expression, we used specific kinase inhibitors (cucurbitacin I for STAT3, U0126 for ERK1/2 and LY294002 for AKT, respectively) prior to leptin treatment. Results showed that LY294002 could significantly suppress leptin-mediated MT1-MMP and KIF1B expression by 84.7 ± 6.8% (P = 0.005) and 81.5 ± 8.5% (P = 0.012, Figure 4D ), respectively. Whereas U0126 showed a partial suppression (53.4 ± 5.6% for MT1-MMP, P = 0.003; 47.6 ± 4.9% for KIF1B, Cell lysate was processed for immunoprecipitation using either anti-KIF1B antibody (top) or NRIg control antibody (middle) and analyzed by western blotting for KIF1B and MT1-MMP. As well, some cell lysate was processed directly for western blotting and analyzed for KIF1B, MT1-MMP and β-actin (bottom). (C) Densitometric analysis was performed on KIF1B and MT1-MMP resulting from immunoprecipitation with a KIF1B antibody. One representative result out of three independent experiments is shown. Each bar represents the mean ± SD (n = 3, *P < 0.05, **P < 0.01, compared with the group of 0 h). P = 0.011; Figure 4E ), no difference was observed in cells treated with cucurbitacin I (Figure 4C ). Moreover, AKT inhibitor could significantly abolish the localization of leptin-mediated MT1-MMP at the cell surface (76.0 ± 8.9%, P = 0.011, Figure 4D ), but not STAT3 or ERK1/2 inhibitor ( Figure 4C and E) . These results suggest that leptin may induce MT1-MMP or KIF1B expression through AKT pathways.
Leptin, MT1-MMP and KIF1B expression in primary GC lesions and their role in GC development
To investigate the correlation of leptin, MT1-MMP and KIF1B in GC and whether these proteins are involved in GC development, we detected the expression of leptin, MT1-MMP and KIF1B in 86 carcinoma tissues and matched adjacent normal tissues by immunohistochemistry. Moderate to strong immunoreactivity (++/+++) for leptin, MT1-MMP and KIF1B was detected in 59.3% (51/86), 63.9% (55/86) and 68.6% (59/86) of carcinoma, respectively. In contrast, only moderate immunoreactivity (++) for these markers was detected in 12.8, 39.5 and 45.4% of normal tissues, respectively ( Figure 5A and B and Table I ). Immunostains revealed that leptin, MT1-MMP and KIF1B expression were both in the cytoplasm and on the cell surface, but not in the nucleus ( Figure 5A ). Western bolt analysis of leptin, MT1-MMP and KIF1B in the above tumor tissues showed consistent results as determined by immunohistochemistry ( Figure 5D ). The differential expression of these three proteins between tumors and normal tissues prompted us to analyze their correlation with clinical and pathologic features. We found that leptin, MT1-MMP and KIF1B were positively correlated with lymph nodes metastasis and clinical stage (Table I) . Most importantly, we found that the levels of these three proteins significantly correlated with one another ( Figure 5C ). These data suggest that the coordination of leptin, MT1-MMP and KIF1B contributes to the GC development.
Discussion
Leptin overexpression is associated with an increased risk for GC and plays critical roles in tumor invasion (39, 42) . However, little is known about the exact mechanism of action of leptin in GC invasion. Elucidating its role might bring new therapeutic strategies for GC. MT1-MMP is overexpressed in several cancers and is implicated in tumor invasion (13) . In this study, we identified a link between Western blotting for OB-RL in the presence or absence of leptin (100 ng/ml) stimulated at 24 h. (B) AGS cells were treated with leptin (100 ng/ml) for various times (0-60 min). The phosphorylation levels of STAT3, ERK1/2 and AKT in the lysates were determined by western blotting with total levels as the internal standard. In separate experiment, AGS cells were treated with STAT3 inhibitor (cucurbitacin I, 20 μM, 2 h) (C), AKT inhibitor (LY294002, 20 μM, 2 h) (D) and ERK1/2 inhibitor (U0126, 20 μM, 2 h) (E), respectively, followed by treatment with or without leptin (100 ng/ml) for 24 h. The inhibitors were present for the duration of leptin treatment. The levels of cell surface MT1-MMP, KIF1B and MT1-MMP were determined. One representative result out of three independent experiments is shown. Graphs show quantitation with β-actin as the internal standard. Each bar represents the mean ± SD (n = 3, *P < 0.05, **P < 0.01). leptin and MT1-MMP expression and demonstrated that leptin could upregulate the intracellular expression and membrane localization of MT1-MMP in vitro. We also identify the role of leptin in GC cell invasion. In particular, KIF1B and AKT are required for leptin-mediated MT1-MMP on the cell surface. Moreover, leptin, MT1-MMP and KIF1B levels strongly correlated to one another in human GC tissues, as well as in clinical stage and lymph node metastasis. These findings indicate a causal connection with clinical relevance between leptin pathway and MT1-MMP in vivo. Together, these observations provide evidence for the first time that KIF1B is involved in leptin-mediated surface localization of MT1-MMP, and the AKT pathway is required for this process, which consequently contributes to the development of GC.
Leptin is a cytokine-like hormone structurally similar to IL-6 and involved in the control of food intake, metabolism and immunity (7) . Previous studies have reported that leptin promotes GC cell proliferation (10, 11) . However, its precise role in GC invasion is unknown. MMPs are critical enzymes during tumor invasion, and studies have showed that leptin may enhance tumor invasion by upregulating MMP-2 (32) or MMP-13 expression (5). Our results showed that leptin could enhance GC cell invasion by upregulating MT1-MMP expression, which is consistent with the finding that leptin is an upstream regulator of MT1-MMP in cardiac fibroblasts (43) . Furthermore, leptin also increased MT1-MMP on the cell surface. This might be due to its effect on MT1-MMP recycling, endocytosis or shedding. Notably, MT1-MMP-siRNA failed to rescue leptin-induced invasion completely, suggesting that other unidentified leptin-activated molecules might contribute to this process. In GC, the MT1-MMPmediated invasion is regulated by MMP-2, ErbB or N-myc downstream-regulated gene-1 expression (23, 44) . However, their effects were not explored in this study. Furthermore, our data also showed that GC cells secrete low levels of leptin. However, the invasion and the expression of MT1-MMP are not affected by anti-leptin mAb compared with control. An explanation may be that endogenously secreted leptin might not reach a sufficient concentration to influence the invasion and the expression of MT1-MMP in GC cells.
MT1-MMP is presented in Golgi-derived vesicles, and its localization on the cell surface is required for protease activity. Here, our results provide a regulatory mechanism that KIF1B regulates leptinmediated surface localization of MT1-MMP in GC. This is consistent with observations that the total MT1-MMP is unaffected by siRNAmediated KIF1B knockdown. The previous study also demonstrates that KIF1B may transport proteins such as GLUT1 C-terminal binding protein (27) . Interestingly, in our study, some KIFs, for instance KIF5B and KIF3A/KIF3B, are not affected by leptin although they had been reported to participate in the MMPs transport in macrophage, such as MMP-9 and MT1-MMP (31) . Taken together, our findings indicate that (i) KIF1B, but not KIF5B and KIF3A/KIF3B, is necessary for the enrichment of leptin-induced MT1-MMP on the cell surface in GC, and (ii) the role of KIFs on MT1-MMP is tissue or cell specific. KIF1B, a member of kinesin 3 family genes, participate in mitochondrial transport (29) and is related to tumor cell apoptosis (45) . Its aberrant expression contributes to tumorigenesis by regulating cell division, including GC cells (30, 46) . Our previous studies also showed that KIF2A promoted the progression and metastasis of SCCOT (28) , and KIF4 inhibited GC cells proliferation (47) . Moreover, specific ablation of KIF1B by siRNA did not result in a complete rescue in leptin-induced cell surface MT1-MMP and cell invasion. This suggests that other molecules may be required for this process, and further experiments will be designed to test these possibilities.
Leptin can simultaneously upregulate expression of KIF1B and MT-MMP. It is difficult to assess the effect of leptin on these proteins. Therefore, we overexpressed MT1-MMP in AGS cells and its expression was not affected by leptin. Our findings revealed that leptin can promote the binding of MT1-MMP with KIF1B in a time-dependent fashion. However, the increased fold of MT1-MMP was more than KIF1B, especially at 48 h, which suggested that leptin not only increased the amount of binding of KIF1B with MT1-MMP but also their binding capacity. The increased binding of KIF1B with MT1-MMP may be a mechanism for the leptin-induced cell surface MT1-MMP, and these alterations might profoundly impact the invasion in several ways. MT1-MMP degrades the surrounding collagen network and is the critical determinant of collagen invasion and matrix degradation (41) . Our data also show that leptin enhances MT1-MMP expression and collagen invasion in GC cells, suggesting a possible role of MT1-MMP in this process. MT1-MMP enhances pro-MMP-2 activation. It can form a ternary complex of MMP-2/TIMP-2/MT1-MMP and activate MMP-2 on the cell membrane (13) . Activated MMP-2 degrades type IV collagen and enhances cancer cell invasion (15) . Accordingly, our findings demonstrate that leptin promotes the expression of MT1-MMP and the activation of MMP-2. In this condition, overexpression of MT1-MMP induced by leptin might efficiently degrade extracellular matrix by accumulating activated MMP-2 on the cell membrane, resulting in the intravasation of cancer cells into the lymphatic vessels. MT1-MMP also directly cleaves cell surface proteins such as CD44 and αv integrins, which are involved in cancer cell invasion (15) . Furthermore, leptin, MT1-MMP and KIF1B strongly correlate positively with lymph nodes metastasis and clinical stage, indicating the possibility that these three proteins are associated with the aggressiveness of GC. Further analysis showed a significant positive relationship among these three proteins in GC tissues, suggesting a regulatory network in vivo. In addition, receiver operating characteristic (ROC) curve analysis also revealed that the combination of MT1-MMP, KIF1B and leptin might be a potential immunobiomarker(s) (data not shown).
Three cytoplasmic tyrosine residues (Tyr974, Tyr985 and Tyr1138) of OB-RL (1162 amino acids) are phosphorylated upon binding activation of leptin, which results in activation of downstream signaling molecules (7) . Our results demonstrated that leptin significantly increased the phosphorylation of STAT3, ERK1/2 and AKT, as seen in previous studies (10, 11) . Previous studies have shown that Type 1 insulin-like growth factor can regulate MT1-MMP by AKT (48) , and leptin induces GC cells proliferation by STAT3 and ERK2 (10) . This suggests a link between leptin signaling and modulation of MT1-MMP levels. Interestingly, we noted that AKT pathway, but not STAT3 pathway, could participate in leptin-stimulated upregulation of MT1-MMP and KIF1B, and ERK1/2 only partly participated in this process. These differences indicate that different signaling pathways regulate different biological functions. Our findings would be able to provide further insight to modulate leptin signaling as a potential therapy target for GC. However, further studies are required. Altogether, our data suggest the critical significance of the leptin pathway in GC cell invasion. This is supported by a recent study from Otvos' group (9) showing that allo-aca, the leptin receptor antagonist peptide, significantly extended average survival time in MDA-MB-231 orthotopic mouse xenograft model. The effect was better than tamoxifen and cisplatin. Taken together, these findings indicate that leptin promotes cell surface MT1-MMP by activating AKT signaling pathways and therefore blocking its action could be a rational therapeutic strategy. The proposed effect of leptin on the KIF1B, and MT1-MMP translocation and generation are summarized in a schematic diagram (Supplementary Figure S7 , available at Carcinogenesis Online).
In summary, our study shows that leptin induces the generation and surface localization of MT1-MMP. Activation of this pathway leads to increased GC cell invasion. We also provide novel evidence that leptin-mediated cell surface localization of MT1-MMP is dependent on KIFB, which implicates the AKT signaling pathway. Therefore, leptin affects the distribution of surface MT1-MMP in invasive cells. Further investigation is needed to determine the effects of leptin on the polarization during invadopodia in GC cell invasion. Our results shed new insight on the mechanisms of cancer cell invasion and provide a potential target against tumor invasion for early progression of GC.
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